| Tapasya Srivastava, MD | |
|
323 Lowell St, Andover, MA 01810-4501 | |
| (978) 794-2112 | |
| (978) 313-8184 |
| Full Name | Tapasya Srivastava |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 25 Years |
| Location | 323 Lowell St, Andover, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467573527 | NPI | - | NPPES |
| 1211382 | Medicaid | MA | |
| J42676 | Other | MA | BLUE CROSS LEGACY PROV# |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 230813 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Partners Healthcare At Home - Home Care | Waltham, MA | Home health agency |
| Lawrence General Hospital | Lawrence, MA | Hospital |
| North Shore Medical Center - | Salem, MA | Hospital |
| Massachusetts General Hospital | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mass General Brigham Community Physicians Inc | 1759273436 | 297 |
News Archive
Inflammatory bowel diseases collectively cause significant lifestyle sacrifices and suffering and millions of dollars in related health care costs every year, partially due to a lack of effective diagnostic procedures and therapies. In new studies presented today at Digestive Disease Week in New Orleans, researchers show evidence of accurate and effective new methods for diagnosis, as well as improved treatment options, for sufferers of ulcerative colitis and Crohn's diseases.
The Houston Chronicle: "Some Republicans who talk about Texas potentially opting out of Medicaid are quick to say the changes wouldn't throw people out on the street — but not House Appropriations Committee Chairman Jim Pitts." Pitts didn't advocate the Medicaid change but "gave a stark answer when an audience member asked about an ill friend who is on Medicaid."
Daiichi Sankyo Europe and Plexxikon Inc., a member of the Daiichi Sankyo Group, announced today that The New England Journal of Medicine published clinical trial results demonstrating that the investigational drug, PLX3397, an oral targeted CSF-1R inhibitor, induced prolonged tumor regressions in most patients with tenosynovial giant cell tumor, a rare, locally aggressive neoplasm of the joint or tendon sheath.
While skin cancer can be deadly, it is also highly treatable when detected early. In fact, melanoma, the deadliest form of skin cancer, has a five-year survival rate of 95 percent when detected and treated before it spreads to the lymph nodes; conversely, the five-year survival rates for regional and distant stage melanomas are 64 percent and 23 percent, respectively.
› Verified 6 days ago
| Entity Name | Mass General Brigham Community Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891112637 PECOS PAC ID: 1759273436 Enrollment ID: O20150723007726 |
News Archive
Inflammatory bowel diseases collectively cause significant lifestyle sacrifices and suffering and millions of dollars in related health care costs every year, partially due to a lack of effective diagnostic procedures and therapies. In new studies presented today at Digestive Disease Week in New Orleans, researchers show evidence of accurate and effective new methods for diagnosis, as well as improved treatment options, for sufferers of ulcerative colitis and Crohn's diseases.
The Houston Chronicle: "Some Republicans who talk about Texas potentially opting out of Medicaid are quick to say the changes wouldn't throw people out on the street — but not House Appropriations Committee Chairman Jim Pitts." Pitts didn't advocate the Medicaid change but "gave a stark answer when an audience member asked about an ill friend who is on Medicaid."
Daiichi Sankyo Europe and Plexxikon Inc., a member of the Daiichi Sankyo Group, announced today that The New England Journal of Medicine published clinical trial results demonstrating that the investigational drug, PLX3397, an oral targeted CSF-1R inhibitor, induced prolonged tumor regressions in most patients with tenosynovial giant cell tumor, a rare, locally aggressive neoplasm of the joint or tendon sheath.
While skin cancer can be deadly, it is also highly treatable when detected early. In fact, melanoma, the deadliest form of skin cancer, has a five-year survival rate of 95 percent when detected and treated before it spreads to the lymph nodes; conversely, the five-year survival rates for regional and distant stage melanomas are 64 percent and 23 percent, respectively.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tapasya Srivastava, MD 323 Lowell St, Andover, MA 01810-4501 Ph: (978) 794-2112 | Tapasya Srivastava, MD 323 Lowell St, Andover, MA 01810-4501 Ph: (978) 794-2112 |
News Archive
Inflammatory bowel diseases collectively cause significant lifestyle sacrifices and suffering and millions of dollars in related health care costs every year, partially due to a lack of effective diagnostic procedures and therapies. In new studies presented today at Digestive Disease Week in New Orleans, researchers show evidence of accurate and effective new methods for diagnosis, as well as improved treatment options, for sufferers of ulcerative colitis and Crohn's diseases.
The Houston Chronicle: "Some Republicans who talk about Texas potentially opting out of Medicaid are quick to say the changes wouldn't throw people out on the street — but not House Appropriations Committee Chairman Jim Pitts." Pitts didn't advocate the Medicaid change but "gave a stark answer when an audience member asked about an ill friend who is on Medicaid."
Daiichi Sankyo Europe and Plexxikon Inc., a member of the Daiichi Sankyo Group, announced today that The New England Journal of Medicine published clinical trial results demonstrating that the investigational drug, PLX3397, an oral targeted CSF-1R inhibitor, induced prolonged tumor regressions in most patients with tenosynovial giant cell tumor, a rare, locally aggressive neoplasm of the joint or tendon sheath.
While skin cancer can be deadly, it is also highly treatable when detected early. In fact, melanoma, the deadliest form of skin cancer, has a five-year survival rate of 95 percent when detected and treated before it spreads to the lymph nodes; conversely, the five-year survival rates for regional and distant stage melanomas are 64 percent and 23 percent, respectively.
› Verified 6 days ago
Madhavi Challagulla, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 323 Lowell St, Andover, MA 01810 Phone: 978-783-5000 Fax: 978-313-8184 | |
Phyllis Spieler, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 138 Haverhill St, Suite 102, Andover, MA 01810 Phone: 978-470-1902 Fax: 978-749-3605 | |
Dr. Spyridon Kantas, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 63 Park Street, Andover, MA 01810 Phone: 978-409-1137 Fax: 978-409-1906 | |
Paul N Lemaitre, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 138 Haverhill St, Suite 203, Andover, MA 01810 Phone: 978-475-7765 Fax: 978-662-2239 | |
Alida Melisa Rosado Rodriguez, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 323 Lowell St, Andover, MA 01810 Phone: 978-783-5000 Fax: 978-313-8182 | |
Constance L Williams, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Unicare- 200 Brickstone Square, Suite #101, Andover, MA 01810 Phone: 978-474-6816 | |
Dr. Chiochen Cheng, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 133 Bailey Rd, Andover, MA 01810 Phone: 978-886-3978 |